HTR2A and cancer: Such antagonists are important coadjuvants in cancer chemotherapy; thus, levomepromazine, primarily acting as a 5HT-2 antagonist at the vomiting center, is useful as a broad-spectrum agent for resistant nausea in cancer chemotherapy, especially in children [30].